Predicted to enable signaling receptor binding activity. Involved in several processes, including cellular response to insulin stimulus; response to activity; and response to caloric restriction. Located in extracellular space. Biomarker of non-alcoholic fatty liver disease; obesity; polycystic ovary syndrome; and type 2 diabetes mellitus. Orthologous to human RARRES2 (retinoic acid receptor responder 2); INTERACTS WITH (+)-schisandrin B; 17alpha-ethynylestradiol; 17beta-estradiol.
RARRES2 protein inhibits the reaction [FSHB protein results in increased abundance of Estradiol] and RARRES2 protein promotes the reaction [Dihydrotestosterone results in decreased abundance of Estradiol]
2-chloro-5-nitrobenzanilide inhibits the reaction [tetrabromobisphenol A results in decreased expression of and results in decreased secretion of RARRES2 protein] more ...
[lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RARRES2 mRNA
[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RARRES2 mRNA
2-chloro-5-nitrobenzanilide inhibits the reaction [bisphenol A results in decreased expression of and results in decreased secretion of RARRES2 protein] more ...
RARRES2 protein inhibits the reaction [Colforsin results in increased expression of CYP11A1 protein] and RARRES2 protein inhibits the reaction [Colforsin results in increased expression of CYP19A1 protein]
[lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RARRES2 mRNA
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RARRES2 mRNA
[lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RARRES2 mRNA
[lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RARRES2 mRNA
[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RARRES2 mRNA
2-chloro-5-nitrobenzanilide inhibits the reaction [tetrachlorodian results in decreased expression of and results in decreased secretion of RARRES2 protein] more ...
NSC 74859 inhibits the reaction [torcetrapib results in increased expression of RARRES2 mRNA] and setanaxib inhibits the reaction [torcetrapib results in increased expression of RARRES2 mRNA]
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RARRES2 mRNA
Different blood pressure responses in hypertensive rats following chemerin mRNA inhibition in dietary high fat compared to dietary high-salt conditions.